Trials / Completed
CompletedNCT00000301
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, amantadine is tested."
Detailed description
16-week participation plus a 2 weekk lead-in period. Participants are assigned randomly to placebo or amantadine. Participants attend group meeting 3 times/week
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amantadine |
Timeline
- Start date
- 1996-03-01
- Primary completion
- 1998-06-01
- First posted
- 1999-09-21
- Last updated
- 2016-07-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000301. Inclusion in this directory is not an endorsement.